Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
1999
NCT00006114
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | Centre Hospitalier Intercommunal Toulon La Seyne sur Mer | Centre Hospitalier Intercommunal Toulon - La Seyne Sur Mer | Department of Intensive Care, Intercommunal hospital, Toulon

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 3)

Inflammation (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 13